Nonoperating Income (Expense) of Freeline Therapeutics Holdings plc from 31 Dec 2019 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Freeline Therapeutics Holdings plc quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 31 Dec 2019 to 31 Mar 2023.
  • Freeline Therapeutics Holdings plc Nonoperating Income (Expense) for the quarter ending 31 Mar 2023 was $21,410,000, a 1366% increase year-over-year.
  • Freeline Therapeutics Holdings plc annual Nonoperating Income (Expense) for 2022 was $9,843,000, a 322% increase from 2021.
  • Freeline Therapeutics Holdings plc annual Nonoperating Income (Expense) for 2021 was $2,330,000, a 63% decline from 2020.
  • Freeline Therapeutics Holdings plc annual Nonoperating Income (Expense) for 2020 was $6,256,000, a 37% decline from 2019.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Freeline Therapeutics Holdings plc Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $21,410,000 +$19,950,000 +1366% 01 Jan 2023 31 Mar 2023 6-K 30 May 2023 2023 Q1
Q1 2022 $1,460,000 +$2,455,000 01 Jan 2022 31 Mar 2022 6-K 30 May 2023 2023 Q1
Q1 2021 $995,000 -$5,613,000 -122% 01 Jan 2021 31 Mar 2021 6-K 10 May 2022 2022 Q1
Q1 2020 $4,618,000 01 Jan 2020 31 Mar 2020 6-K 17 May 2021 2021 Q1

Freeline Therapeutics Holdings plc Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $9,843,000 +$7,513,000 +322% 01 Jan 2022 31 Dec 2022 20-F 04 Apr 2023 2022 FY
2021 $2,330,000 -$3,926,000 -63% 01 Jan 2021 31 Dec 2021 20-F 04 Apr 2023 2022 FY
2020 $6,256,000 -$3,620,000 -37% 01 Jan 2020 31 Dec 2020 20-F 04 Apr 2023 2022 FY
2019 $9,876,000 01 Jan 2019 31 Dec 2019 20-F 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.